+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type



The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type



Journal of Medical Economics 16(1): 43-54



Descriptions of the inpatient experience for patients hospitalized with systolic heart failure (HF) are limited and lack a cross-sectional representation of the US population. While length of stay (LOS) is a primary determinant of resource use and post-discharge events, few models exist for estimating LOS. MarketScan(®) administrative claims data from 1/1/2005-6/30/2008 were used to select hospitalized patients aged ≥18 years with discharge diagnoses for both HF (primary diagnosis) and systolic HF (any diagnostic position) without prior HF hospitalization or undergoing transplantation. Among 17,597 patients with systolic HF; 4109 had commercial; 2118 had Medicaid; and 11,370 had Medicare payer type. Medicaid patients had longer mean LOS (7.1 days) than commercial (6.3 days) or Medicare (6.7 days). In-hospital mortality was highest for patients with Medicaid (2.4%), followed by Medicare (1.3%) and commercial (0.6%). Commercial patients were more likely to receive inpatient procedures. Renal failure, pressure ulcer, malnutrition, a non-circulatory index admission DRG, receipt of a coronary artery bypass procedure or cardiac catheterization, or need for mechanical ventilation during the index admission were associated with increased LOS; receipt of a pacemaker device at index was associated with shorter LOS. Selection of patients with systolic HF is limited by completeness and accuracy of medical coding, and results may not be generalizable to patients with diastolic HF or to international populations. Inpatient care, LOS, and in-hospital survival differ by payer among patients hospitalized with systolic HF, although co-morbidity and inpatient procedures consistently influence LOS across payer types. These findings may refine risk stratification, allowing for targeted intensive inpatient management and/or aggressive transitional care to improve outcomes and increase the efficiency of care.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056387011

Download citation: RISBibTeXText

PMID: 22954063

DOI: 10.3111/13696998.2012.726932


Related references

Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure. Circulation. Heart Failure 5(6): 672-679, 2013

Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 303(21): 2141-2147, 2010

Comparison of Length of Stay, 30-Day Mortality, and 30-Day Readmission Rates in Medicare Patients With Heart Failure and With Reduced Versus Preserved Ejection Fraction. American Journal of Cardiology 118(1): 79-85, 2017

Implementation of the American heart association get with the guidelines heart failure program (GWTG-HF) reduces length of stay and decreases cost for hospitalized heart failure patients at St. Joseph's Regional Medical Center (SJRMC). 2007

A comparison of inpatient severity, average length of stay, and cost for traditional fee-for-service medicare and medicare HMOs in Florida. Health Care Management Review 29(4): 320-328, 2004

Comparison of In-Hospital Mortality and Length-Of-Stay Predictors Between Elderly and Non-Elderly Acute Decompensated Heart Failure Patients at a Tertiary Heart Center in Malaysia. International Journal of Cardiology 273: 6-7, 2018

Emergency room utilization of continuous intravenous furosemide together with the American Heart Association get with the guideline heart failure care (GWTG-HF) decreases length of stay for hospitalized heart failure patients at St. Joseph's Regional Medical Center (SJRMC). 2007

Variation in length of stay in patients hospitalized with congestive heart failure. American Journal of Managed Care 5(6): 800-802, 1999

Early Ambulation Among Hospitalized Heart Failure Patients Is Associated With Reduced Length of Stay and 30-Day Readmissions. Circulation. Heart Failure 11(4): E004634, 2018

Impact of anemia on length of stay, charges, and mortality in hospitalized patients with heart failure. Circulation 108(17 Suppl.): IV-755, October 28, 2003

Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure. Jacc. Heart Failure 5(8): 578-588, 2017

Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States. JAMA Cardiology 2019, 2019

Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. American Journal of Managed Care 5(6): 715-723, 1999

Constipation prophylaxis reduces length of stay in elderly hospitalized heart failure patients with home laxative use. Journal of Gastroenterology and Hepatology 30(11): 1596-1602, 2016

Admission characteristics predicting longer length of stay among elderly patients hospitalized for decompensated heart failure. European Journal of Internal Medicine 19(3): 198-202, 2008